145 related articles for article (PubMed ID: 908615)
21. Antibodies in blood and secretions of chickens immunized parenterally and locally with killed Newcastle disease virus vaccine.
Katz D; Kohn A
Dev Biol Stand; 1976; 33():290-6. PubMed ID: 955276
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of cyclophosphamide-treated chickens against Newcastle disease virus infection.
Lam KM; Hao Q
Vet Microbiol; 1987 Oct; 15(1-2):41-8. PubMed ID: 3439013
[TBL] [Abstract][Full Text] [Related]
23. Aerosol vaccination of chickens with the V4 strain of Newcastle disease virus.
Schalkoort R; Spradbrow PB
Aust Vet J; 1980 Sep; 56(9):429-33. PubMed ID: 7458782
[TBL] [Abstract][Full Text] [Related]
24. Effect of breeder vaccination on immunization of progeny against Newcastle disease.
Giambrone JJ; Closser J
Avian Dis; 1990; 34(1):114-9. PubMed ID: 2322221
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin class distribution of systemic and mucosal antibody responses to Newcastle disease in chickens.
Al-Garib SO; Gielkens AL; Gruys DE; Hartog L; Koch G
Avian Dis; 2003; 47(1):32-40. PubMed ID: 12713156
[TBL] [Abstract][Full Text] [Related]
26. The serological responses of chickens to mass vaccination with a live V4 Newcastle disease virus vaccine in the field and in the laboratory. 1. Meat chickens.
Bell IG; Nicholls PJ; Norman C; Cooper K; Cross GM
Aust Vet J; 1991 Mar; 68(3):85-9. PubMed ID: 2043095
[TBL] [Abstract][Full Text] [Related]
27. Laboratory evaluation of Newcastle disease vaccination programs for broiler chickens.
Giambrone JJ
Avian Dis; 1985; 29(2):479-87. PubMed ID: 4026739
[TBL] [Abstract][Full Text] [Related]
28. Observations on the transmissibility of lentogenic strains of Newcastle disease virus: significance of variables.
Spalatin J; Turner AJ; Hanson RP
Avian Dis; 1976; 20(2):361-8. PubMed ID: 938383
[TBL] [Abstract][Full Text] [Related]
29. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
30. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
[TBL] [Abstract][Full Text] [Related]
31. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of avian paramyxovirus serotypes 2 to 10 as vaccine vectors in chickens previously immunized against Newcastle disease virus.
Tsunekuni R; Hikono H; Saito T
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):184-91. PubMed ID: 24880702
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Impact of Different Administration Routes on the Efficacy of a Thermoresistant Newcastle Disease Vaccine in Chickens.
Hassanzadeh M; Abdoshah M; Yousefi AR; Masoudi S
Viral Immunol; 2020 Jun; 33(5):361-366. PubMed ID: 31976824
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
[TBL] [Abstract][Full Text] [Related]
37. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
[TBL] [Abstract][Full Text] [Related]
38. A comparison of various routes of Newcastle Disease vaccination at one day of age.
Eidson CS; Kleven SH
Poult Sci; 1976 Sep; 55(5):1778-87. PubMed ID: 995805
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
[TBL] [Abstract][Full Text] [Related]
40. Newcastle disease antibody levels in chickens after vaccination with oil emulsion adjuvant killed vaccine.
Box PG; Furminger IG
Vet Rec; 1975 Feb; 96(5):108-11. PubMed ID: 1114647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
